CN1778961A - Determination of magnesium ion content from enzyme method and magnesium ion diagnostic reagent kit - Google Patents

Determination of magnesium ion content from enzyme method and magnesium ion diagnostic reagent kit Download PDF

Info

Publication number
CN1778961A
CN1778961A CN 200410065554 CN200410065554A CN1778961A CN 1778961 A CN1778961 A CN 1778961A CN 200410065554 CN200410065554 CN 200410065554 CN 200410065554 A CN200410065554 A CN 200410065554A CN 1778961 A CN1778961 A CN 1778961A
Authority
CN
China
Prior art keywords
magnesium ion
acid
reagent
ethyl
reduced form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200410065554
Other languages
Chinese (zh)
Inventor
王尔中
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suzhou ANJ Biotech Co Ltd
Original Assignee
Suzhou ANJ Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suzhou ANJ Biotech Co Ltd filed Critical Suzhou ANJ Biotech Co Ltd
Priority to CN 200410065554 priority Critical patent/CN1778961A/en
Publication of CN1778961A publication Critical patent/CN1778961A/en
Pending legal-status Critical Current

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention is about the enzyme method of measuring magnesium ion and its diagnosis reagent box. Making use of the peculiarity that magnesium ion in the sample of plasma or serum and so on can activate the activation of glycerokinase, and producing glycerol-3-phosphoryl by reacting glycerol under the existence of adenosine triphosphate, and then causing coupled reaction with glycerol-3-phosphoryl dehydrogenase, peroxidase and oxidating the colorless reduced chromogen combination to quinoneimine chromogen or indamide chromogen dyer with color, testing the ascending range of 400-600nmabsorbance and finally measuring the content of Inorganic Phosphates This method has high specificity and would not be contaminated by material of internal and exogenous sources, and the result is precise and accurate. Diving the diagnosis reagent box into double-dose or three-dose can reduces the cross interaction of each element, keeps the stability of the reagent and deposits chronically. Using this method can realize the fast testing in common ultraviolet/ visible light analyzer or semiautomatic/automatic analyzer and doesn't require special or additional apparatus, so the cost is low. Thus, this method can be easily promoted and applied in the whole industry.

Description

The method of enzymatic assays magnesium ion content and magnesium ion diagnostic kit
Technical field
The present invention relates to the method for magnesium ion content in the samples such as enzymatic assays blood plasma, serum, and use the formulated magnesium ion diagnostic kit of this method, belong to medical test determination techniques field.
Background technology
The means of medically measuring magnesium ion content (abbreviation magnesium determination) in the samples such as blood plasma, serum at present are many, summarize to get up to have: colorimetry, fluorescent method, ion chromatography, ion specific electrode method (ISE), enzyme process, atomic absorption spectrophotometry (AAS), isotopic dilution mass spectrometry (ID-MS) etc.Wherein conclusive method is ID-MS, secondly is AAS, though these two kinds of method results are accurate, equipment complexity, expense costliness are not suitable for Routine Test Lab and analysis automatically.
Colorimetry is most widely used method, comprising: methyl thymol blue method (MTB), titan yellow method, OCPC method (OCPC), calmagite method (Calmagite) and 2-(8 '-hydroxyquinoline-5 '-sulfonic acid-7 '-azo)-variable color acid system (8Q5SAC) of reporting recently.Colorimetry is easy and simple to handle, expense is low, is fit to Routine Test Lab and uses, but have reagent blank absorbancy height, be subject to bilirubin and other positively charged ion disturbs, reagent stability is poor, and contain in the reagent and be corrosive or shortcoming such as toxic component.Ion specific electrode method (ISE) can be measured magnesium ion activity in the physiological solution, adopts neutral carrier (ETH7025) liquid film ion selective electrode, and the accuracy of mensuration is higher, but still exists the calcium in the physiological range to disturb Ca 2+Maximum interference reaches 10%.Ion chromatography needed sample is carried out pre-treatment before measuring, and comprised acidifying dilution and filtration.This method of uses such as Thienpont is analyzed with the definite value serum of atomic absorption spectrophotometry five kinds " international standard and technology meetings ", average deviation is 0.35% only as a result, thinks that ion chromatography can be used as the valuable reference method of measuring the magnesium elements total amount.
Magnesium ion (mainly is Mg in the samples such as enzymatic assays blood plasma, serum 2+) research very active in recent years, obtained bigger progress.Be applied to Mg at present 2+The Enzymology method of measuring has: 1. hexokinase and glucose-6-phosphate dehydrogenase coupling method; 2. glycerol kinase, GPO and superoxide enzyme coupling method; 3. glucokinase and glucose-6-phosphate dehydrogenase coupling method; 4. enzyme joins chemoluminescence method; 5. phosphoglucomutase and glucose-6-phosphate dehydrogenase coupling method; 6. isocitric enzyme method; 7. pyruvate kinase and lactic dehydrogenase enzyme coupling method.
On the whole, employing enzyme process detection magnesium ion result is accurate, interference is little, be suitable for automated analysis.But, use different detection reagent and test route, the sensitivity of detection, the accuracy of detected result have very big difference, directly have influence on the use and the popularization of this method, and this is the people reason place constantly studying in the field, develop and innovate just.Because extraordinary application prospect arranged, the research that enzyme process is detected magnesium ion has become the focus in this field.
Summary of the invention
The objective of the invention is: a kind of method of enzymatic assays magnesium ion content is provided, and uses the formulated magnesium ion diagnostic kit of this method.Adopt the reagent in this test kit, can utilize ultraviolet analyser or semi-automatic/automatic clinical chemistry analyzer that the content of magnesium ion in the samples such as blood plasma, serum is carried out fast, accurately measures, so that promote the use of method and corresponding diagnostic kit that enzyme process detects magnesium ion, make this field in detection means obtain further abundant and develop.
For realizing purpose of the present invention, a kind of method of enzymatic assays magnesium ion content, adopt following steps to carry out:
At first,, make it to take place following reaction with needs such as blood plasma, serum sample of measuring and the reagent mixing that contains glycerine, adenosine triphosphate, glycerol kinase, glycerol-3-phosphate oxidase, peroxidase and the combination of reduced form chromogen,
Then, reaction mixture is placed under ultraviolet analyser or the semi-automatic/automatic clinical chemistry analyzer, detect the ascensional range of the absorbancy of predominant wavelength 400~600nm, and then calculate the content of magnesium ion in the sample.
Above-mentioned " combination of reduced form chromogen " is to be made of reduced form chromogen A and another B component.Reduced form chromogen A is: " 3-methyl-2-Proxel hydrazone " (English MBTH that is called for short, full name is 3-methyl-2-benzothiazolinone-hydrszone) or " the amino anti-arsenic Yun of 4-" (English full name is 4-aminoantipyrine); Another B component is one of following 15 kinds of materials:
1. PHENOL 99.8 MIN ((CARBOLIC ACID)) (phenol),
2. N-ethyl-N-(3-thiopropyl)-m-thialdine amine (N-ethyl-N-(3-sulfopropyl)-m-anisidine, be called for short ESPAS),
3. N, the two ethyls of N--m-Tolylamine (N, N-Diethyl-m-toluidine),
4. 2, the two chlorine PHENOL 99.8 MIN ((CARBOLIC ACID)) of 4-(2,4-Dichloriphenol),
5. 2,4,6-three bromo-3-hydroxyl-Phenylsulfonic acid (2,4,6-Tribromo-3-hydroxy-benzenesulfonic acid is called for short TBHB),
6. 3, the two chlorine PHENOL 99.8 MIN ((CARBOLIC ACID)) sulfonic acid (3,5-Dichlorophenolsulfonic acid) of 5-,
7. 3, the two chloro-2-hydroxyl-Phenylsulfonic acids of 5-(3,5-Dichloro-2-hydroxy-benzenesulfonicacid is called for short DHBS),
8. N-ethyl n-(2-hydroxyl-3-thiopropyl)-m-Tolylamine sodium salt (N-ethyl-N-(2-hydroxy-3-sulfopropyl)-m-toluidine sodium, be called for short TOOS),
9. three bromine hydroxy-benzoic acid (Tribromohydroxybenzoic acid),
10. two monomethylanilines (Dimethylaniline is called for short DMA),
(11) N-ethyl-N-(2-hydroxyl-3-thiopropyl)-m-Tolylamine (be called for short EHSPT, full name is N-Ethyl-N-(2-hydroxy-3-sulfopropyl)-m-toluidine),
(12) 2,2 '-Lian nitrogen-two (3-ethyl benzo thiazole phenanthroline-6-sulfonic acid) di-ammonium salts (2,2 '-azino-bis-(3-ethylbenzthiazoline-6-sulfonic acid), be called for short ABTS),
(13) 2,2 '-azino-two (3-ethyl benzo thiophene pyrrolines-6-sulfonic acid), English name is 2,2 '-azino-bis-(3-ethylbenztbiozoline-6-sulfonic acid),
(14) vanillic acid (Vanillic acid (4-hydroxy-3-methoxybenzoicacid) is called for short HMB),
(15) 3-methyl-ethyl-hydroxyanilines (3-methyl-ethyl-hydroxyaniline is called for short MEHA).
In the mensuration process, the usage ratio of sample and reagent by volume was controlled at 1: 10~1: 500, and temperature of reaction is controlled at 20 ℃~50 ℃, and the reaction times was controlled at 2~30 minutes, set commplementary wave length during detection more than 500~700nm.
The magnesium ion diagnostic kit of realizing the inventive method can be single agent, is grouped into by following one-tenth:
Damping fluid 40~200mmol/l,
Glycerine 1~40mmol/l,
Adenosine triphosphate 0.2~20mmol/l,
Glycerol kinase 1000~50000U/l,
Glycerol-3-phosphate oxidase 1000~50000U/l,
Peroxidase 500~50000U/l,
Reduced form chromogen combination 0.1~20mmol/l,
Stablizer/reagent cumulative volume 10~80%.
Wherein the implication of " combination of reduced form chromogen " as previously mentioned, the concentration of two kinds of component A and B is 0.1~20mmol/l.
Also the various compositions in above single agent can be carried out formulated in combination and become two agent, be beneficial to eliminate the pollution of inside and outside source material, such as:
Peroxidase 500~50000U/l
Reduced form chromogen combination (one) 0.1~20mmol/l
Stablizer/reagent I cumulative volume 10~80%
Reagent II Damping fluid 40~200mmol/l
Glycerol kinase 1000~50000U/l
Reduced form chromogen combination (two) 0.1~20mmol/l
Stablizer/reagent II cumulative volume 10~80%
Wherein, reduced form chromogen combination () can be: the amino anti-arsenic Yun of 3-methyl-2-Proxel hydrazone or 4-; Reduced form chromogen combination (two) can be one of aforementioned 15 kinds of materials.
The prescription of two agent is not limited only in the above-mentioned table listed, reductibility chromogen combination (one) and (two) can transposition, and the composition of reagent I---glycerine, adenosine triphosphate, glycerol-3-phosphate oxidase, peroxidase etc. can be placed on reagent II; Glycerol kinase among the reagent II also can be put into reagent I, so can form multiple formulations, enumerates no longer one by one.
Reagent can also be made into following three reagent, not only more help eliminating the pollution of inside and outside source material, it is more stable to also help reagent:
Figure A20041006555400091
Agent III Glycerol kinase 1000~50000U/l
Reduced form chromogen combination (two) 0.1~20mmol/l
Stablizer/reagent III cumulative volume 10~80%
Similar with two agent, reduced form chromogen combination () can be the amino anti-arsenic Yun of 3-methyl-2-Proxel hydrazone or 4-in three doses, and combination (two) can be one of aforementioned 15 kinds of materials.
Three doses prescription also is not limited only to above-mentioned prescription, reduced form chromogen combination (one) and (two) can divide to come and is placed on any position of reagent I, II or III, the composition of reagent I---glycerine and adenosine triphosphate can be placed among reagent II or the reagent III, composition among the reagent II---glycerol-3-phosphate oxidase and peroxidase can be placed among reagent I or the reagent III, glycerol kinase among the reagent III also can be placed in the middle of reagent I or the reagent II, so can form multiple formulations, enumerate no longer one by one.
In the middle of the composition of above-mentioned diagnostic kit, selecting the basic demand of damping fluid is that pH value is within 6.0~11.0 scopes, can be: " Tutofusin tris~hydrochloric acid (Tris-HCl) damping fluid ", " trolamine (Triethanolamine) damping fluid ", " 2-amino-2-methyl-1-propanol (2-Amino-2-methyl-1-propanol) damping fluid ", " imidazoles~hydrochloric acid (Imidazole-HCl) damping fluid ", " glycylglycine (Glycylglycine) damping fluid ", " citric acid~sodium citrate buffer solution ", " Veronal sodium~hydrochloride buffer ", " boric acid~borate buffer solution ", " glycine~sodium hydrate buffer solution ", " borax~sodium hydrate buffer solution ", at least a in " phosphoric acid (Phosphate) damping fluid " or " phosphoric acid salt (Phosphate-Sodium Chloride; PBS) damping fluid ", but range of choice be not subjected to these enumerate limit.
In addition, for reducing the cross influence between each reagent composition, the stability of maintenance reagent, so that standing storage, usually add stablizer in the middle of the reagent I/ reagent II of above single agent, two agent, three doses the reagent I/ reagent II/ reagent III, its consumption accounts for 10~80% (perhaps concentration is within 10~50mmol/l scopes) of place reagent cumulative volume.
Material with used as stabilizers can be: at least a in ethylene glycol, propylene glycol, glycerine, ammonium sulfate, thioglycol, adenosine diphosphate (ADP), bovine serum albumin, carbonate, cholate, dextran, ethylenediamine tetraacetic acid (EDTA), flavin adenine dinucleotide, vitamin B2 phosphate, glucose, glutaminate, reduced glutathion, lactose, N.F,USP MANNITOL, succinate or the sodium-chlor.
No matter studies show that, take all factors into consideration from the accuracy of measurement result and economy two aspects of preparation cost, be single agent, two agent or three doses, and the magnesium ion diagnostic kit of following system component relation is comparatively desirable, also is preferred version of the present invention:
Damping fluid 80~120mmol/l,
Glycerine 10~20mmol/l,
Adenosine triphosphate 2~8mmol/l,
Glycerol kinase 10000~30000U/l,
Glycerol-3-phosphate oxidase 10000~30000U/l,
Peroxidase 10000~30000U/l,
Reduced form chromogen combination 0.1~10mmol/l,
Stablizer/reagent cumulative volume 10~50%.
The present invention uses magnesium ion and activates the active characteristics of glycerol kinase, the degree that the glycerol kinase activity intensifies is directly proportional with the content of magnesium ion in the samples such as blood plasma, serum, in the presence of adenosine triphosphate, generate glycerol-3-phosphate with glycerine reaction, the coupling glycerol-3-phosphate oxidase produces hydrogen peroxide again, hydrogen peroxide and peroxidase reaction are oxidized to coloured quinone-imine chromogen (Quioneimine) or indoleamine chromogen (Indamine) dyestuff with colourless reduced form chromogen (Chromogen) combined system.Because the absorbing wavelength difference of different dyes in 400~600nm scope has well quantitatively corresponding relation between dyestuff content and the absorbancy, therefore, the absorbancy of measuring between the reaction period changes, and just can reflect the content of magnesium ion in the sample well.
The outstanding substantive distinguishing features and the obvious improvement of technical solution of the present invention mainly shows:
(1) the present invention utilizes Enzymology method fully, enzyme digestion reaction has the high characteristics of specificity, by colourless reduced form chromogen combination is oxidized to coloured quinone-imine chromogen or indoleamine chromogen dyestuff, quantitative response goes out the content of magnesium ion in the sample, and test result is accurate;
(2) composition of participation enzyme linked reaction all adds, and is not subjected to the pollution of inside and outside source material, test process tolerance range height;
(3) this method is easy, easy to operate, can obtain detected result fast, and the reaction be under buffer conditions, to carry out, do not pollute the environment;
(4) but this method just rapid detection on general ultraviolet/visible light analysis instrument or semi-automatic/automatic clinical chemistry analyzer does not need special or additional instruments, testing cost is cheap, is convenient to apply in the industry;
(5) use the reagent that measuring method provided by the invention can be made various ways such as liquid reagent, powdered reagent, dried reagent, be mainly used in the content of measuring magnesium ion in human body and other animal body, also can be, supplementary means such as concentrate and measure magnesium ion in other sample in conjunction with dilution;
(6) liquid magnesium ion diagnostic kit provided by the invention, good stability, the three-D space structure that is present in wherein each kind of enzyme is kept perfectly, and has guaranteed the application testing effect well.Make after two agent or three doses, can further reduce the cross influence between the various compositions, detected result is more credible, and reagent is more stable, can store for a long time.
Embodiment
Below in conjunction with specific embodiment technical solution of the present invention is described further.These examples only are some exemplary applications, can not be interpreted as a kind of restriction to claim protection domain of the present invention.
Embodiment one (single agent)
Prepare magnesium ion diagnostic kit in the serum by following composition and consumption:
Glycylglycine damping fluid 80mmol/l,
Glycerine 10mmol/l,
Adenosine triphosphate 2mmol/l,
Glycerol kinase 10000U/l,
Glycerol-3-phosphate oxidase 10000U/l,
Peroxidase 10000U/l,
The amino anti-arsenic Yun 2mmol/l of 4-,
PHENOL 99.8 MIN ((CARBOLIC ACID)) 10mmol/l,
Ethylene glycol 50% (accounting for the reagent cumulative volume).
Go up to set at automatic clinical chemistry analyzer (Hitachi-7080): 37 ℃ of temperature, 10 minutes reaction times, test predominant wavelength 495~505nm, more than the test commplementary wave length 600nm, the volume ratio of sample and reagent is 1: 25, the Direction of Reaction is positive reaction (absorbancy rises, down together).
Adding serum sample and the single agent that is made into, both detect, write down the rising situation of 495~505nm absorbancy at the inner mixing automatically of analyser.Detect altogether and read a little 31 times, approximately every 20 seconds record one secondary data, according to methods such as rate method, end-point methods, the contrast corresponding standard curve calculates the content of magnesium ion in the serum sample.Same batch sample is repeatedly repeated above process, test result good reproducibility, tolerance range height.
Embodiment two (two agent)
Prepare magnesium ion diagnostic kit in the serum by following composition and consumption:
Reagent I---
Imidazoles~hydrochloride buffer 100mmol/l,
Glycerine 15mmol/l,
Adenosine triphosphate 5mmol/l,
Glycerol-3-phosphate oxidase 20000U/l,
Peroxidase 20000U/l,
The amino anti-arsenic Yun 1mmol/l of 4-,
Ethylene glycol 50% (accounting for reagent I cumulative volume);
Reagent II---
Imidazoles~hydrochloride buffer 100mmol/l,
Glycerol kinase 20000U/l,
2,4,6-three bromo-3-hydroxyl-Phenylsulfonic acid 1mmol/l,
Ethylene glycol 50% (accounting for reagent II cumulative volume).
Go up to set at automatic clinical chemistry analyzer (Hitachi-7080): 30 ℃ of temperature, 15 minutes reaction times, test predominant wavelength 546nm, more than the test commplementary wave length 630nm, sample is 1: 25 with the ratio of the cumulative volume of reagent I and reagent II, reagent I is 4: 1 with the ratio of the consumption of reagent II, and the Direction of Reaction is positive reaction.
Adding serum sample and reagent I add reagent II after 5 minutes earlier, and the three detects, writes down the rising situation of 546nm absorbancy at the inner mixing automatically of analyser.According to methods such as rate method, end-point methods, the contrast corresponding standard curve calculates the content of magnesium ion in the serum sample.Same batch sample is repeatedly repeated above process, test result good reproducibility, tolerance range height.
Embodiment three (three doses)
Prepare magnesium ion diagnostic kit in the serum by following composition and consumption:
Reagent I---
Trolamine damping fluid 120mmol/l,
Glycerine 20mmol/l,
Adenosine triphosphate 8mmol/l,
3-methyl-2-Proxel hydrazone 2mmol/l,
Propylene glycol 20mmol/l;
Reagent II---
Trolamine damping fluid 120mmol/l,
Glycerol-3-phosphate oxidase 30000U/l,
Peroxidase 30000U/l,
Propylene glycol 50% (accounting for reagent II cumulative volume);
Reagent III---
Trolamine damping fluid 120mmol/l,
Glycerol kinase 30000U/l,
Two monomethylaniline 2mmol/l,
Ethylene glycol 50% (accounting for reagent III cumulative volume).
Go up to set at automatic clinical chemistry analyzer (Hitachi-7080): 25 ℃ of temperature, 20 minutes reaction times, test predominant wavelength 578nm, more than the test commplementary wave length 700nm, sample is 1: 25 with the ratio of the cumulative volume of reagent I, reagent II and reagent III, the consumption of reagent I, reagent II and reagent III is 8: 1: 1, and the Direction of Reaction is positive reaction.
Adding serum sample and reagent I, reagent II add reagent III after 5 minutes earlier, and they detect, write down the rising situation of 578nm absorbancy at the inner mixing automatically of analyser.According to methods such as rate method, end-point methods, the contrast corresponding standard curve calculates the content of magnesium ion in the serum sample.Same batch sample is repeatedly repeated above process, test result good reproducibility, tolerance range height.
Embodiment four (two agent preference)
Prepare the serium inorganic phosphorus diagnostic kit by following composition and consumption:
Reagent I---
Tris-HCl damping fluid 100mmol/l,
Glycerine 10mmol/l,
Adenosine triphosphate 3mmol/l,
The amino anti-arsenic Yun 1mmol/l of 4-,
Ammonium sulfate 20mmol/l;
Reagent II---
Tris-HCl damping fluid 100mmol/l,
Glycerol-3-phosphate oxidase 15000U/l,
Glycerol kinase 15000U/l,
Peroxidase 15000U/l,
Two monomethylaniline 2mmol/l,
Ammonium sulfate 20mmol/l.
Go up to set at automatic clinical chemistry analyzer (Hitachi-7080): 30 ℃ of temperature, 10 minutes reaction times, test predominant wavelength 578nm, more than the test commplementary wave length 700nm, sample is 1: 25 with the ratio of the cumulative volume of reagent I and reagent II, reagent I is 4: 1 with the ratio of the consumption of reagent II, and the Direction of Reaction is positive reaction.
Add serum sample and reagent I earlier, add reagent II after 5 minutes, following principle reaction takes place at the inner mixing automatically of analyser in the three:
Detect, write down the rising situation of 578nm absorbancy.According to methods such as rate method, end-point methods, the contrast corresponding standard curve calculates the content of magnesium ion in the serum sample.Same batch sample is repeatedly repeated above process, test result good reproducibility, tolerance range height.
In a word, experimental results show that and adopt measuring method of the present invention, can pass through ultraviolet analyser or semi-automatic/automatic clinical chemistry analyzer device fully, determine the content of magnesium ion in the samples such as blood plasma, serum, measurement sensitivity height, tolerance range are good, are not subjected to the pollution of inside and outside source material.And, magnesium ion diagnostic kit provided by the invention, good stability still can accurately detect the magnesium ion content in all kinds sample after the long storage time.

Claims (9)

1. the method for an enzymatic assays magnesium ion content may further comprise the steps:
1. with testing sample and the reagent mixing that contains glycerine, adenosine triphosphate, glycerol kinase, glycerol-3-phosphate oxidase, peroxidase and the combination of reduced form chromogen, make it to take place following reaction,
2. reaction mixture is placed under ultraviolet analyser or the semi-automatic/automatic clinical chemistry analyzer, detect the ascensional range of the absorbancy of predominant wavelength 400~600nm, calculate the content of magnesium ion in the sample.
2. the method for enzymatic assays magnesium ion content according to claim 1, it is characterized in that: described " combination of reduced form chromogen " is to be made of reduced form chromogen A and another B component, reduced form chromogen A is " a 3-methyl-2-Proxel hydrazone " or " the amino anti-arsenic Yun of 4-", another B component is one of following 15 kinds of materials: PHENOL 99.8 MIN ((CARBOLIC ACID)), N-ethyl-N-(3-thiopropyl)-m-thialdine amine, N, the two ethyls of N--m-Tolylamine, 2, the two chlorine PHENOL 99.8 MIN ((CARBOLIC ACID)) of 4-, 2,4,6-three bromo-3-hydroxyl-Phenylsulfonic acid, 3, the two chlorine PHENOL 99.8 MIN ((CARBOLIC ACID)) sulfonic acid of 5-, 3, the two chloro-2-hydroxyl-Phenylsulfonic acids of 5-, N-ethyl-N-(2-hydroxyl-3-thiopropyl)-m-Tolylamine sodium salt, three bromine hydroxy-benzoic acid, two monomethylanilines, N-ethyl-N-(2-hydroxyl-3-thiopropyl)-m-Tolylamine, 2,2 '-Lian nitrogen-two (3-ethyl benzo thiazole phenanthroline-6-sulfonic acid) di-ammonium salts, 2,2 '-azino-two (3-ethyl benzo thiophene pyrrolines-6-sulfonic acid), vanillic acid, 3-methyl-ethyl-hydroxyanilines.
3. the method for enzymatic assays magnesium ion content according to claim 1 and 2, it is characterized in that: the usage ratio of testing sample and reagent by volume was controlled at 1: 10~1: 500, temperature of reaction is controlled at 20 ℃~50 ℃, reaction times was controlled at 2~30 minutes, set commplementary wave length during detection more than 500~700nm.
4. magnesium ion diagnostic kit, reagent is grouped into by following one-tenth in the box:
Damping fluid 40~200mmol/l,
Glycerine 1~40mmol/l,
Adenosine triphosphate 0.2~20mmol/l,
Glycerol kinase 1000~50000U/l,
Glycerol-3-phosphate oxidase 1000~50000U/l,
Peroxidase 500~50000U/l,
Reduced form chromogen combination 0.1~20mmol/l,
Stablizer/reagent cumulative volume 10~80%.
5. magnesium ion diagnostic kit according to claim 4 is characterized in that:
Described " combination of reduced form chromogen " is to be made of reduced form chromogen A and another B component, and the concentration of A and B is 0.1~20mmol/l;
Reduced form chromogen A is " a 3-methyl-2-Proxel hydrazone " or " the amino anti-arsenic Yun of 4-";
Another B component is one of following 15 kinds of materials: PHENOL 99.8 MIN ((CARBOLIC ACID)), N-ethyl-N-(3-thiopropyl)-m-thialdine amine, N, the two ethyls of N--m-Tolylamine, 2, the two chlorine PHENOL 99.8 MIN ((CARBOLIC ACID)) of 4-, 2,4,6-three bromo-3-hydroxyl-Phenylsulfonic acid, 3, the two chlorine PHENOL 99.8 MIN ((CARBOLIC ACID)) sulfonic acid of 5-, 3, the two chloro-2-hydroxyl-Phenylsulfonic acids of 5-, N-ethyl-N-(2-hydroxyl-3-thiopropyl)-m-Tolylamine sodium salt, three bromine hydroxy-benzoic acid, two monomethylanilines, N-ethyl-N-(2-hydroxyl-3-thiopropyl)-m-Tolylamine, 2,2 '-Lian nitrogen-two (3-ethyl benzo thiazole phenanthroline-6-sulfonic acid) di-ammonium salts, 2,2 '-azino-two (3-ethyl benzo thiophene pyrrolines-6-sulfonic acid), vanillic acid, 3-methyl-ethyl-hydroxyanilines.
6. according to claim 4 or 5 described magnesium ion diagnostic kits, it is characterized in that: the PH scope of described damping fluid is 6.0~11.0.
7. magnesium ion diagnostic kit according to claim 6 is characterized in that: described damping fluid is " Tutofusin tris~hydrochloride buffer ", " trolamine damping fluid ", " 2-amino-2-methyl-1-propanol damping fluid ", " imidazoles~hydrochloride buffer ", " glycylglycine damping fluid ", " citric acid~sodium citrate buffer solution ", " Veronal sodium~hydrochloride buffer ", " boric acid~borate buffer solution ", " glycine~sodium hydrate buffer solution ", " borax~sodium hydrate buffer solution ", at least a in " phosphoric acid buffer " or " phosphate buffered saline buffer ".
8. according to claim 4 or 5 described magnesium ion diagnostic kits, it is characterized in that: described stablizer is at least a in ethylene glycol, propylene glycol, glycerine, ammonium sulfate, thioglycol, adenosine diphosphate (ADP), bovine serum albumin, carbonate, cholate, dextran, ethylenediamine tetraacetic acid (EDTA), flavin adenine dinucleotide, vitamin B2 phosphate, glucose, glutaminate, reduced glutathion, lactose, N.F,USP MANNITOL, succinate or the sodium-chlor.
9. any magnesium ion diagnostic kit in the claim 4~8 is characterized in that: described reagent is made into single agent, two agent or three doses.
CN 200410065554 2004-11-23 2004-11-23 Determination of magnesium ion content from enzyme method and magnesium ion diagnostic reagent kit Pending CN1778961A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200410065554 CN1778961A (en) 2004-11-23 2004-11-23 Determination of magnesium ion content from enzyme method and magnesium ion diagnostic reagent kit

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200410065554 CN1778961A (en) 2004-11-23 2004-11-23 Determination of magnesium ion content from enzyme method and magnesium ion diagnostic reagent kit

Publications (1)

Publication Number Publication Date
CN1778961A true CN1778961A (en) 2006-05-31

Family

ID=36769416

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200410065554 Pending CN1778961A (en) 2004-11-23 2004-11-23 Determination of magnesium ion content from enzyme method and magnesium ion diagnostic reagent kit

Country Status (1)

Country Link
CN (1) CN1778961A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114774511A (en) * 2022-04-12 2022-07-22 广州万德康科技有限公司 Reaction liquid for detecting magnesium ions in blood sample, dry test paper and preparation method thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114774511A (en) * 2022-04-12 2022-07-22 广州万德康科技有限公司 Reaction liquid for detecting magnesium ions in blood sample, dry test paper and preparation method thereof
CN114774511B (en) * 2022-04-12 2024-05-10 广州万德康科技有限公司 Reaction liquid for detecting magnesium ions in blood sample, dry test paper and preparation method thereof

Similar Documents

Publication Publication Date Title
CN1769481A (en) Blood ammonia content determination method and blood ammonia diagnosis kit
CN1778961A (en) Determination of magnesium ion content from enzyme method and magnesium ion diagnostic reagent kit
CN1778963A (en) Determination of blood ammonia content and blood ammonia diagnostic reagent kit
CN1778943A (en) Determination of inorganic phosphorus and its diagnostic reagent kit
CN1778941A (en) Determination of inorganic phosphorus and its diagnostic reagent kit
CN1778962A (en) Determination of magnesium ion content from enzyme method and magnesium ion diagnostic reagent kit
CN1778958A (en) Determination of magnesium ion content from enzyme method and magnesium ion diagnostic reagent kit
CN1778956A (en) Determination of magnesium ion content from enzyme method and magnesium ion diagnostic reagent kit
CN1778944A (en) Determination of creatinine content and creatinine diagnostic reagent kit
CN1778957A (en) Determination of magnesium ion content from enzyme method and magnesium ion diagnostic reagent kit
CN1778960A (en) Determination of magnesium ion content from enzyme method and magnesium ion diagnostic reagent kit
CN1778955A (en) Determination of inorganic phosphorus and its diagnostic reagent kit
CN1778942A (en) Determination of inorganic phosphorus and its diagnostic reagent kit
CN1778959A (en) Determination of magnesium ion content from enzyme method and magnesium ion diagnostic reagent kit
CN1786187A (en) Enzymatic method for determining potassium ion content and potassium ion diagnosis kit
CN1786692A (en) Process for determining content of potassium ion by enzyme method and kit for diagnosing potassium ion thereof
CN1778953A (en) Determination of inorganic phosphorus and its diagnostic reagent kit
CN1778954A (en) Determination of inorganic phosphorus and its diagnostic reagent kit
CN1778952A (en) Determination of inorganic phosphorus and its diagnostic reagent kit
CN1302119C (en) Method for measuring 5'-nucleotidase activity and diagnostic reagent kit of 5'-nucleotidase
CN1789427A (en) Monoamine oxidase activity determination method and monoamine oxidase diagnostic kit
CN1786691A (en) Process for determining contect of potassium ion by enzyme method and kit for diagnosing potassium ion thereof
CN1786693A (en) Process for determining content of chlorine ion and kit for diagnosing chlorine ion therefor
CN1789426A (en) Monoamine oxidase activity determination method and monoamine oxidase diagnostic kit
CN1778937A (en) Determination of blood ammonia content and blood ammonia diagnostic reagent kit

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication